Current concepts. Primary sclerosing cholangitis.

PubWeight™: 2.35‹?› | Rank: Top 2%

🔗 View Article (PMID 6366557)

Published in N Engl J Med on April 05, 1984

Authors

N F LaRusso, R H Wiesner, J Ludwig, R L MacCarty

Articles citing this

IgG4-related sclerosing disease. World J Gastroenterol (2008) 3.84

Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol (2006) 3.40

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut (2005) 2.22

Orthotopic liver transplantation for primary sclerosing cholangitis. Ann Surg (1988) 1.89

Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. Ann Surg (1993) 1.63

Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect? Transplantation (1988) 1.61

Clinical significance of antibodies against neutrophils in patients with inflammatory bowel disease and primary sclerosing cholangitis. Gut (1992) 1.60

Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut (1986) 1.58

Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg (1997) 1.16

Primary sclerosing cholangitis in Japan--analysis of 192 cases. J Gastroenterol (1997) 1.08

Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function tests. Gut (1990) 1.06

Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology (1990) 1.05

Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial. Am J Gastroenterol (1995) 1.05

Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis. Dig Dis Sci (1991) 0.97

The interrelation between sclerosing cholangitis and ulcerative colitis in patients undergoing liver transplantation. Ann Surg (1992) 0.96

Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases. J Gastroenterol (2010) 0.96

Sclerosing cholangitis associated with autoimmune pancreatitis differs from primary sclerosing cholangitis. World J Gastroenterol (2009) 0.96

Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease. Int J Colorectal Dis (2004) 0.95

Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis. Gut (2001) 0.94

Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg (1989) 0.92

Surgical aspects of sclerosing cholangitis. Results in 178 patients. Ann Surg (1990) 0.88

Primary sclerosing cholangitis--what is the difference between east and west? World J Gastroenterol (2008) 0.88

Successful treatment of recurrent primary sclerosing cholangitis after orthotopic liver transplantation with oral vancomycin. Case Rep Transplant (2013) 0.86

Transjugular portosystemic shunt for treatment of bleeding stomal varices. Dig Dis Sci (1997) 0.86

Immunological similarities between primary sclerosing cholangitis and chronic sclerosing sialadenitis: report of the overlapping of these two autoimmune diseases. Dig Dis Sci (2000) 0.83

Primary sclerosing cholangitis with elevated serum IgG4 levels and/or infiltration of abundant IgG4-positive plasma cells. J Gastroenterol (2009) 0.83

The role of peroral video cholangioscopy in patients with IgG4-related sclerosing cholangitis. J Gastroenterol (2012) 0.82

Sclerosing cholangitis and biliary tract calculi--primary or secondary? Gut (1992) 0.81

Development and characterization of a rodent model of immune-mediated cholangitis. Proc Natl Acad Sci U S A (1996) 0.81

Liver lesions found at colectomy in ulcerative colitis: correlation between histological findings and biochemical parameters. J Clin Pathol (1994) 0.80

Localized primary sclerosing cholangitis mimicking a cholecystectomy stricture relieved by an endoprosthesis. Postgrad Med J (1991) 0.80

Colonic cancer in a patient with primary sclerosing cholangitis and long-standing ulcerative colitis. J Gastroenterol (1997) 0.79

Ulcerative colitis after renal transplantation: A case report and review of literature. Indian J Nephrol (2011) 0.78

The value of thioredoxin family proteins and proliferation markers in dysplastic and malignant gallbladders in patients with primary sclerosing cholangitis. Dig Dis Sci (2012) 0.78

Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses. Gut (1991) 0.77

Histological and immunohistochemical study of the gall bladder lesion in primary sclerosing cholangitis. Gut (1991) 0.77

Gallbladder emptying in patients with primary sclerosing cholangitis. World J Gastroenterol (2009) 0.75

An autopsy case showing massive fibrinoid necrosis of the portal tracts of the liver with cholangiographic findings similar to those of primary sclerosing cholangitis. World J Gastroenterol (2007) 0.75

Inappropriate expression of blood group antigens on biliary and colonic epithelia in primary sclerosing cholangitis. Gut (1993) 0.75

Sclerosing cholangitis rapidly following anti-HIV-1 seroconversion. Genitourin Med (1991) 0.75

Bile duct antibodies crossreacting with blood group antigens in primary sclerosing cholangitis. Gut (1990) 0.75

An atypical presentation for primary sclerosing cholangitis. Dig Dis Sci (1997) 0.75

Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods. Gut (1991) 0.75

Sclerosing pancreatitis presenting as a periampullary tumour. HPB (Oxford) (2003) 0.75

Cholangiocarcinoma and malignant bile duct obstruction: A review of last decades advances in therapeutic endoscopy. World J Gastrointest Endosc (2015) 0.75

Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases. Can J Gastroenterol (2012) 0.75

Intrahepatic segmental primary sclerosing cholangitis: report of a case. Surg Today (2006) 0.75

Articles by these authors

A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc (1980) 8.36

Biliary tract cancers. N Engl J Med (1999) 6.36

Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol (1995) 4.68

Simplified assessment of segmental colonic transit. Gastroenterology (1987) 4.59

Natural history of untreated colonic polyps. Gastroenterology (1987) 3.69

Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology (1980) 3.57

Intracellular anions as the voltage sensor of prestin, the outer hair cell motor protein. Science (2001) 2.99

Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78

Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology (1998) 2.75

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol (1978) 2.63

Incidental extracolonic findings at CT colonography. Radiology (2000) 2.40

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology (1989) 2.39

Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res (2000) 2.38

Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med (1997) 2.38

Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl (2000) 2.27

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol (2000) 2.25

The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology (1989) 2.19

Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16

The long-term pathological evolution of chronic hepatitis C. Hepatology (1996) 2.15

Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology (1994) 2.10

Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 2.06

Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res (2001) 2.05

Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest (1990) 1.99

Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94

Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94

A new route to nucleoside 5'-triphosphates. Acta Biochim Biophys Acad Sci Hung (1981) 1.93

Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc (1989) 1.93

Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver. Gastroenterology (1989) 1.89

Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology (1982) 1.88

Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest (1987) 1.88

Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant (2008) 1.86

pH gating of ROMK (K(ir)1.1) channels: control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome. Proc Natl Acad Sci U S A (1999) 1.85

A letter to the next speaker. Mayo Clin Proc (1973) 1.85

Lumbar epidural perineural injection: a new technique. Eur Spine J (1997) 1.85

Monooctanoin, a dissolution agent for retained cholesterol bile duct stones: physical properties and clinical application. Gastroenterology (1980) 1.84

Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol (2000) 1.83

Reaction of bone to methacrylate after hip arthroplasty: a long-term gross, light microscopic, and scanning electron microscopic study. J Bone Joint Surg Am (1974) 1.81

A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med (1990) 1.81

Serum ferritin and the iron status of Canadians. Can Med Assoc J (1976) 1.79

Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78

Morphological, molecular, and functional heterogeneity of cholangiocytes from normal rat liver. Gastroenterology (1996) 1.76

Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study. Gastroenterology (1990) 1.76

Control of ligand specificity in cyclic nucleotide-gated channels from rod photoreceptors and olfactory epithelium. Proc Natl Acad Sci U S A (1991) 1.75

Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart (2001) 1.74

Optimization of CT colonography technique: prospective trial in 180 patients. Radiology (2000) 1.72

A prospective comparison of molecular diagnostic techniques for the early detection of cytomegalovirus in liver transplant recipients. J Infect Dis (1995) 1.71

Whipple's disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc (1988) 1.71

Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis. J Hepatol (2000) 1.70

A physiological role for ether-à-go-go K+ channels? Trends Neurosci (1997) 1.69

Patients with asymptomatic primary sclerosing cholangitis frequently have progressive disease. Gastroenterology (1990) 1.69

Detection of cytomegalovirus DNA in sera of liver transplant recipients. J Clin Microbiol (1994) 1.69

Heterogeneity of the proliferative capacity of rat cholangiocytes after bile duct ligation. Am J Physiol (1998) 1.68

The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient. Liver Transpl Surg (1997) 1.68

Chronic vitamin A intoxication in adults. Hepatic, neurologic and dermatologic complications. Am J Med (1971) 1.67

Extracellular Mg2+ regulates activation of rat eag potassium channel. Pflugers Arch (1996) 1.66

Ischemic cholangitis in hepatic allografts. Mayo Clin Proc (1992) 1.66

Recent advances in the isolation of liver cells. Hepatology (1994) 1.63

Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. Ann Surg (1993) 1.63

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology (1996) 1.62

Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia. Stroke (2003) 1.61

Oligonucleotide duplexes containing 2'-amino-2'-deoxycytidines: thermal stability and chemical reactivity. Nucleic Acids Res (1994) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

Computed tomography of the liver. AJR Am J Roentgenol (1977) 1.60

Clinical and radiologic features of cerebral edema in fulminant hepatic failure. Mayo Clin Proc (1995) 1.59

Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis. Mayo Clin Proc (1993) 1.59

Nephrotoxic effects of primary immunosuppression with FK-506 and cyclosporine regimens after liver transplantation. Mayo Clin Proc (1994) 1.59

Dynamics of the enterohepatic circulation of bile acids. Postprandial serum concentrations of conjugates of cholic acid in health, cholecystectomized patients, and patients with bile acid malabsorption. N Engl J Med (1974) 1.58

De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant (2014) 1.57

Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations. N Engl J Med (1985) 1.57

Development and characterization of polarized primary cultures of rat intrahepatic bile duct epithelial cells. Lab Invest (1996) 1.56

Detection of colorectal polyps with CT colography: initial assessment of sensitivity and specificity. Radiology (1997) 1.55

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54

Histological evidence for recurrence of primary biliary cirrhosis after liver transplantation. Hepatology (1993) 1.53

Flawed gun policy research could endanger public safety. Am J Public Health (1997) 1.53

Great Lakes embryo mortality, edema, and deformities syndrome (GLEMEDS) in colonial fish-eating birds: similarity to chick-edema disease. J Toxicol Environ Health (1991) 1.52

Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol (2001) 1.52

Primary sclerosing cholangitis: refinement and validation of survival models. Gastroenterology (1992) 1.51

Primary sclerosing cholangitis: findings on cholangiography and pancreatography. Radiology (1983) 1.49

Morbidity and mortality in cirrhotic patients undergoing anesthesia and surgery. Anesthesiology (1999) 1.49